$29.20
0.34% day before yesterday
NYSE, Dec 27, 10:00 pm CET
ISIN
US0718131099
Symbol
BAX

Baxter International Stock price

$29.20
-4.11 12.34% 1M
-4.32 12.89% 6M
-9.46 24.47% YTD
-9.46 24.47% 1Y
-57.40 66.28% 3Y
-54.85 65.26% 5Y
-11.22 27.76% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.10 0.34%
ISIN
US0718131099
Symbol
BAX
Sector

Key metrics

Market capitalization $14.91b
Enterprise Value $26.75b
P/E (TTM) P/E ratio 127.34
EV/FCF (TTM) EV/FCF 47.94
EV/Sales (TTM) EV/Sales 1.91
P/S ratio (TTM) P/S ratio 1.07
P/B ratio (TTM) P/B ratio 1.89
Dividend yield 3.56%
Last dividend (FY24) $1.04
Revenue growth (TTM) Revenue growth -6.44%
Revenue (TTM) Revenue $13.99b
EBIT (operating result TTM) EBIT $1.30b
Free Cash Flow (TTM) Free Cash Flow $558.00m
Cash position $1.42b
EPS (TTM) EPS $0.23
P/E forward 55.80
P/S forward 1.41
EV/Sales forward 2.54
Short interest 3.17%
Show more

Is Baxter International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Baxter International Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Baxter International forecast:

3x Buy
18%
12x Hold
71%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a Baxter International forecast:

Buy
18%
Hold
71%
Sell
12%

Financial data from Baxter International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
13,988 13,988
6% 6%
100%
- Direct Costs 8,815 8,815
8% 8%
63%
5,173 5,173
4% 4%
37%
- Selling and Administrative Expenses 2,166 2,166
3% 3%
15%
- Research and Development Expense 630 630
2% 2%
5%
2,377 2,377
11% 11%
17%
- Depreciation and Amortization 1,076 1,076
15% 15%
8%
EBIT (Operating Income) EBIT 1,301 1,301
7% 7%
9%
Net Profit 116 116
139% 139%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Baxter International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Baxter International Stock News

Neutral
Business Wire
10 days ago
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com...
Neutral
Business Wire
18 days ago
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024. “Our Pharmaceuticals teams are relentlessly ...
Positive
Reuters
23 days ago
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.
More Baxter International News

Company Profile

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Head office United States
CEO Joe Almeida
Employees 60,000
Founded 1931
Website www.baxter.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today